Medicare Benefits Schedule - Item 38416

Search Results for Item 38416

View Associated Notes

Category 3 - THERAPEUTIC PROCEDURES

38416

38416 - Additional Information

Item Start Date:
01-Mar-2021
Description Updated:
01-Mar-2021
Schedule Fee Updated:
01-Jul-2021

Group
T8 - Surgical Operations
Subgroup
6 - Cardio-Thoracic
Subheading
5 - Thoracic Surgery

Endoscopic ultrasound guided fine needle aspiration biopsy or biopsies (endoscopy with ultrasound imaging) to obtain one or more specimens from either or both of the following:

(a) mediastinal masses;

(b) locoregional nodes to stage non-small cell lung carcinoma;

other than a service associated with a service to which an item in Subgroup 1 of this Group, or item 38417 or 55054, applies 

Multiple Operation Rule

(Anaes.)

Fee: $586.15 Benefit: 75% = $439.65 85% = $498.25

(See para TN.8.21 of explanatory notes to this Category)


Associated Notes

Category 3 - THERAPEUTIC PROCEDURES

TN.8.21

Endoscopic or Endobronchial Ultrasound +/- Fine Needle Aspiration - (Items 30688 - 30694, 38416 - 38417)

For the purposes of these items the following definitions apply: 

Biopsy  means the removal of solid tissue by core sampling or forceps

FNA  means aspiration of cellular material from solid tissue via a small gauge needle. 

The provider should make a record of the findings of the ultrasound imaging in the patient's notes for any service claimed against items 30688 to 30694, 38416 and 38417. 

Endoscopic ultrasound  is an appropriate investigation for patients in whom there is a strong clinical suspicion of pancreatic neoplasia with negative imaging (such as CT scanning). Scenarios include, but are not restricted to:

-           A middle aged or elderly patient with a first attack of otherwise unexplained (eg negative abdominal CT) first episode of acute pancreatitis; or

-           A patient with biochemical evidence of a neuroendocrine tumour.

The procedure is not claimable for periodic surveillance of patients at increased risk of pancreatic cancer, such as chronic pancreatitis. However, EUS would be appropriate for a patient with chronic pancreatitis in whom there was a clinical suspicion of pancreatic cancer (eg: a pancreatic mass occurring on a background of chronic pancreatitis).

 

Related Items: 30688 30690 30692 30694 38416 38417


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change